Cited by 134Lysosomal Storage Disorders ResearchVirus-based gene therapy researchRNA Interference and Gene Delivery

AAV gene transfer delays disease onset in a TPP1-deficient canine model of the late infantile form of Batten disease

Open access
Katz, Martin L., Tecedor, Luis, Chen, Yonghong, Williamson, Baye G., Lysenko, Elena, Wininger, Fred A., Young, Whitney M., Johnson, Gayle C. +3 more·2015·Science Translational Medicine

Abstract

AAV-mediated gene transfer to ependymal cells in a dog model of Batten disease provides sustained enzyme replacement and delays disease onset.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1126/scitranslmed.aac6191

Cites

36 of 36 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The slow pulsatile flow of the CSF allows movement of the vector around the brain without additional surgeries for effective coverage of the CNS.

    “the slow pulsatile flow of the CSF allows movement of the vector around the brain without additional surgeries for effective coverage of the CNS”

    From AAVrh.10-Mediated APOE2 Central Nervous System Gene Therapy for APOE4-Associated Alzheimer's Disease (2018) · cites this paper as [89]

    The Introduction describes a single unilateral rAAV infusion, and the Discussion says CSF-based delivery can avoid major neurosurgery while producing broad TPP1 distribution in dogs. But the Results attribute widespread brain coverage to TPP1 protein secreted by transduced ependymal cells, not to vector moving throughout the brain. The paper does not describe CSF flow as slow or pulsatile. (LLM, conf=0.86)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. [22]Vuillemenot BR Kennedy D Cooper JD Wong AMS Sri S Doeleman T Katz ML Coates JR Johnson GC Reed RP Adams EL Butt MT Musson DG Henshaw J Keve S Cahayag R Tsuruda LS O’Neill CA Nonclinical evaluation of CNS-administered TPP1 enzyme replacement in canine CLN2 neuronal ceroid lipofuscinosis Mol Genet Metab 114 281 293 2015 25257657

Cited by

Sorted by citations

Authors
Katz, M. L., Tecedor, L., Chen, Y., Williamson, B. G., Lysenko, E., Wininger, F. A., Young, W. M., Johnson, G. C., Whiting, R. E. H., Coates, J. R., & Davidson, B. L.
Affiliations
  • University of Missouri (US)
  • Children's Hospital of Philadelphia (US)
  • The Raymond G. Perelman Center for Cellular and Molecular Therapeutics, The Children’s Hospital of Philadelphia, Philadelphia, PA 19104, USA.
Corresponding author
  • Katz, Martin L.
  • Tecedor, Luis
  • Chen, Yonghong
  • Davidson, Beverly L.
Venue
Science Translational Medicine
Published
2015-11-11
Volume
7
Issue
313
Pages
313ra180-313ra180
ISSN
  • 1946-6234 (ISSN-L)
  • 1946-6242
OpenAlex
W2174260594
Cited by
134
References
36
Citations by year
2026: 4 · 2025: 7 · 2024: 9 · 2023: 13 · 2022: 15 · 2021: 15 · 2020: 14 · 2019: 16 · 2018: 17 · 2017: 15 · 2016: 8 · 2015: 1
FWCI
10.07
Type
journal article
Language
en
Open access
Locations
  • Science Translational Medicine (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • NIH (NS068099, NS077516, EY023968)
  • Roy J. Carver Trust
  • Batten Disease Support and Research Association
  • Children's Hospital of Philadelphia Research Institute
  • Jasper Against Batten Fund at Partnership for Cures
  • Blake's Purpose Foundation
Topics
  • Health Sciences › Medicine › Physiology › Lysosomal Storage Disorders Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
Keywords
Batten disease, late infantile neuronal ceroid lipofuscinosis, tripeptidyl peptidase 1, recombinant adeno-associated virus, gene therapy, canine model, lysosomal storage disease, neurodegeneration, cognitive decline, lifespan extension
MeSH terms
Tripeptidyl-Peptidase 1, Dependovirus, Aminopeptidases, Animals, Cerebral Ventricles, Dipeptidyl-Peptidases and Tripeptidyl-Peptidases, Disease Models, Animal, Dogs, Genetic Vectors, Neuronal Ceroid-Lipofuscinoses, Transduction, Genetic, Enzyme Replacement Therapy, Serine Proteases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review